Show Notes
Today, we're covering the recent FDA approval of a new Olanzapine long-acting injectable - Weltruza.
References: https://pubmed.ncbi.nlm.nih.gov/41632432/ https://pubmed.ncbi.nlm.nih.gov/42198294/ https://www.tevapharm.com/news-and-media/latest-news/new-long-term-safety-data-from-the-completed-phase-3-solaris-trial-support-the-potential-of-olanzapine-la/
More from PsychRounds: The Psychiatry Podcast
Welcome back, everyone! We’re back after PRITE, and today we’re discussing pharmacogenetic testing.
Today, we will discuss GLP-1's and the emerging use of this class of medications in psychiatry.
We resume our landmark studies series looking at the pivotal study in Major Depressive Disorder (MDD), The STAR*D (Sequenced Treatment Alternatives to Relieve Depression) trial.
We have a special guest today to talk about one of our favorite topics... dogs! Most people might intuitively say that they feel like their dogs improve their mental health, but today, we look at the science with the leading expert on the subject.
Welcome back! Today, we are talking about Simtriyo, which has generated a lot of media attention recently given a newly minted FDA approval for ADHD.